세계의 피부과용 영상 기기 시장 규모, 점유율 및 동향 분석 보고서 : 모달리티별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Dermatology Imagine Devices Market Growth & Trends:

The global dermatology imaging devices market size is anticipated to reach USD 5.60 billion by 2030 and it is projected to grow at a CAGR of 13.09% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of skin disorders such as cancer, and inflammatory dermatoses, among others are the major contributing factors for market growth. For instance, according to the International Agency for Research on Cancer, in 2022, globally 331, 722 cases of melanoma cancer were reported, the cases are further estimated to reach 1,262,756 by 2027. Furthermore, technological advancements are also expected to propel market growth.

Dermatology imaging devices are efficient as they provide non-invasive, high-resolution visualization of skin lesions and other related conditions. They help dermatologists by providing detailed morphology, structure, and traits of diverse skin abnormalities, which thereby help in precise diagnosis and treatment strategizing. Moreover, they enable remote consultation, assist specialists to exchange images and expertise, thereby enhancing patient care.

Technological advancements in dermatology imaging devices such as high-resolution images, integration with AI, 3D imaging are further expected to contribute to the market growth. For instance, ,in June 2023, FotoFinder Systems GmbH, a prominent manufacturer of medical imaging systems for dermatology, has recently unveiled two new cutting-edge innovations - the meesma, a portable imaging solution for aesthetics, and the fourth generation FotoFinder ATBM master equipped with an AI assistant called AIMEE for Total Body Dermoscopy. These state-of-the-art systems are showcased for the first time to experts at the "25th World Congress of Dermatology" (WCD) in Singapore, scheduled from 3rd to 8th July 2023.

Market participants are implementing a range of strategic initiatives to maintain competitiveness and expand their market share. These initiatives include product launch, government approval, expansion, partnership, merger, and acquisitions. In May 2023,Orlucent's skin fluorescence imaging system has been granted Breakthrough Device Designation (BDD) by the US Food and Drug Administration (FDA).t's a handheld point-of-care device that provides molecular-level imaging and analysis of moles. This innovative tool can identify and assess biological tissue-remodeling activity associated with the development of abnormal moles in adults, all without requiring invasive procedures.

Dermatology Imaging Devices Market Report Highlights:

• Based on modality, the dermatoscope segment led the market with the largest revenue share of 41.42% in 2023, Also, the digital photographic imaging segment is anticipated to grow at the fastest CAGR during the forecast period
• Based on application, the skin cancer segment held the market with the largest revenue share of 48.63% in 2023. On other hand, the plastic and reconstructive surgery segment is expected to grow at the fastest CAGR during the forecast period
• Based on end-use, the hospitals held the market with the largest revenue share of 43.99% in 2023. And, the dermatology centers segment is expected to grow at a fastest CAGR over the forecast period.
• North America dominated the market with the revenue share of 39.48% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Dermatology Imaging Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of skin disorders and skin cancers
    • 3.2.1.2. Growing awareness for the early disease diagnosis
    • 3.2.1.3. Rising demand for non-invasive diagnostic procedures
    • 3.2.1.4. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of awareness about the benefits of dermatology imaging
    • 3.2.2.2. High cost of dermatology imaging devices
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Increasing demand for portable and handheld imaging devices
    • 3.2.3.2. Growing healthcare expenditure in emerging economies
• 3.3. Dermatology Imaging Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Dermatology Imaging Devices Market: Modality Estimates & Trend Analysis

• 4.1. Modality Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Dermatology Imaging Devices Market by Modality Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Digital Photographic Imaging
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Optical Coherence Tomography (OCT)
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Dermatoscope
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. High Frequency Ultrasound
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dermatology Imaging Devices Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Dermatology Imaging Devices Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Skin Cancers
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Inflammatory Dermatoses
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.2. Skin psoriasis
    • 5.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.3. Eczema (Atopic dermatitis)
    • 5.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.4. Others
    • 5.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Plastic and Reconstructive Surgery
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dermatology Imaging Devices Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Dermatology Imaging Devices Market by End Use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Dermatology Centers
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Specialty Clinics
  • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dermatology Imaging Devices Market: Regional Estimates & Trend Analysis by Country, Modality, Application, and End Use

• 7.1. Regional Market Dashboard
• 7.2. Global Regional Market Snapshot
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Reimbursement structure
    • 7.4.1.4. Competitive scenario
    • 7.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Reimbursement structure
    • 7.4.2.4. Competitive scenario
    • 7.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Reimbursement structure
    • 7.5.1.4. Competitive scenario
    • 7.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Reimbursement structure
    • 7.5.2.4. Competitive scenario
    • 7.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Reimbursement structure
    • 7.5.3.4. Competitive scenario
    • 7.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Reimbursement structure
    • 7.5.4.4. Competitive scenario
    • 7.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Reimbursement structure
    • 7.5.5.4. Competitive scenario
    • 7.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Reimbursement structure
    • 7.5.6.4. Competitive scenario
    • 7.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Reimbursement structure
    • 7.5.7.4. Competitive scenario
    • 7.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Reimbursement structure
    • 7.5.8.4. Competitive scenario
    • 7.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Reimbursement structure
    • 7.6.1.4. Competitive scenario
    • 7.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Reimbursement structure
    • 7.6.2.4. Competitive scenario
    • 7.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Reimbursement structure
    • 7.6.3.4. Competitive scenario
    • 7.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Reimbursement structure
    • 7.6.4.4. Competitive scenario
    • 7.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Reimbursement structure
    • 7.6.5.4. Competitive scenario
    • 7.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Reimbursement structure
    • 7.6.6.4. Competitive scenario
    • 7.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Reimbursement structure
    • 7.7.1.4. Competitive scenario
    • 7.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Mexico
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Reimbursement structure
    • 7.7.2.4. Competitive scenario
    • 7.7.2.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Reimbursement structure
    • 7.7.3.4. Competitive scenario
    • 7.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Reimbursement structure
    • 7.8.1.4. Competitive scenario
    • 7.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Reimbursement structure
    • 7.8.2.4. Competitive scenario
    • 7.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Reimbursement structure
    • 7.8.3.4. Competitive scenario
    • 7.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Reimbursement structure
    • 7.8.4.4. Competitive scenario
    • 7.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key Company Market Share Analysis, 2023
• 8.4. Company Position Analysis, 2023
• 8.5. Company Categorization (Emerging Players, Innovators, and Leaders)
• 8.6. Company Profiles
  • 8.6.1. Canfield Scientific, Inc.
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. FotoFinder Systems GmbH
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. e-con Systems Inc.
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. Courage+Khazaka electronic GmbH
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. Longport, Inc.
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Cortex Technology
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. DRAMINSKI S. A.
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. GE HealthCare
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. VisualSonics
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives
  • 8.6.10. Clarius
    • 8.6.10.1. Company overview
    • 8.6.10.2. Financial performance
    • 8.6.10.3. Product benchmarking
    • 8.6.10.4. Strategic initiatives
  • 8.6.11. Koninklijke Philips N.V.
    • 8.6.11.1. Company overview
    • 8.6.11.2. Financial performance
    • 8.6.11.3. Product benchmarking
    • 8.6.11.4. Strategic initiatives
  • 8.6.12. Michelson Diagnostics Ltd (MDL)
    • 8.6.12.1. Company overview
    • 8.6.12.2. Financial performance
    • 8.6.12.3. Product benchmarking
    • 8.6.12.4. Strategic initiatives
  • 8.6.13. Caliber Imaging and Diagnosis
    • 8.6.13.1. Company overview
    • 8.6.13.2. Financial performance
    • 8.6.13.3. Product benchmarking
    • 8.6.13.4. Strategic initiatives
  • 8.6.14. DermLite
    • 8.6.14.1. Company overview
    • 8.6.14.2. Financial performance
    • 8.6.14.3. Product benchmarking
    • 8.6.14.4. Strategic initiatives